Thyrocare appoints Rajdeep Panwar as chief commercial officer

Thyrocare Technologies has named Rajdeep Panwar as its new Chief Commercial Officer (CCO), a key leadership appointment aimed at strengthening the company’s market reach and revenue growth initiatives. In this role, Panwar will oversee commercial operations, refine go-to-market strategies and spearhead efforts to expand the brand’s footprint across segments.

Panwar brings extensive experience in healthcare and diagnostics, with a proven track record in sales leadership, strategic partnerships, and business development. His expertise will be central to enhancing Thyrocare’s engagement with clients, healthcare providers and channel partners, while aligning commercial goals with evolving industry dynamics.

As CCO, Panwar will focus on driving growth through innovative customer solutions, strengthened distribution networks and deeper penetration into both urban and emerging markets. He will also lead initiatives that leverage data insights and consumer trends to optimise service offerings and enhance customer experience.

This appointment reflects Thyrocare’s emphasis on solid commercial leadership to support its expansion aims in a competitive and rapidly evolving diagnostics landscape. Panwar’s experience positions him well to navigate market challenges, identify new opportunities and contribute to the company’s long-term strategic vision.